[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Biochemistry](https://durgical.com/en/biochemistry/) › Lysosomal storage diseases

[Biochemistry](https://durgical.com/en/biochemistry/) · Topic

# Lysosomal storage diseases

When a lysosomal enzyme is missing, the molecule it should break down stays inside, the lysosome swells and the cell eventually fails.

Updated 2026-11-01

## Key facts

- More than 70 single-gene diseases; together about 1 in 5,000 live births.
- Mechanism: loss of an acid hydrolase, its activator protein, mannose 6-phosphate tagging, or a carrier that exports products from the lysosome.
- Groups: sphingolipidoses (Gaucher, Tay–Sachs, Niemann–Pick, Fabry, Krabbe, metachromatic leukodystrophy), mucopolysaccharidoses (Hurler, Hunter), glycogenosis II (Pompe), mucolipidoses (I-cell disease).
- The organ hit depends on where the substrate turns over most: gangliosides in neurons, glucosylceramide in macrophages, GAGs in connective tissue.
- Nearly all are autosomal recessive; Fabry and Hunter are X-linked.

## In detail

- 1. Material reaches the lysosome by endocytosis, phagocytosis or autophagy and should leave as monomers (sugars, amino acids, fatty acids).
- 2. If one enzyme fails, its intermediate substrate builds up and lysosomes grow until they distort the cell (Gaucher cells, foam cells).
- 3. Storage disturbs autophagy, membrane traffic and calcium, and triggers inflammation; the cell dies or works poorly.
- 4. Residual enzyme activity sets the severity: no activity, infantile form; some activity, juvenile or adult forms.
- 5. Diagnosis: enzyme activity in leukocytes or dried blood spots, substrates in urine (GAGs, oligosaccharides) or blood, and genetic testing.
- 6. Treatments: enzyme replacement (the recombinant enzyme enters through the mannose 6-phosphate or mannose receptor), substrate reduction, pharmacological chaperones, haematopoietic stem cell transplant, and gene therapy under study.
- 7. Infused enzyme does not cross the blood–brain barrier well: replacement improves organs and bone but helps the brain little.

**Also called**
Lysosomal storage disorders

## Clinical notes

- Clinical clues: hepatosplenomegaly, developmental regression, coarse facial features, dysostosis multiplex, cherry-red spot or corneal clouding.
- Foam cells or Gaucher cells in bone marrow support the diagnosis, which is confirmed by enzyme and gene testing.
- Families are offered genetic counselling, and prenatal diagnosis when the variant is known.

## Pathways

- [Lysosomal ganglioside breakdown](https://durgical.com/en/biochemistry/pathways/lysosomal-ganglioside-breakdown/)

## Related conditions

- [Gaucher disease](https://durgical.com/en/conditions/gaucher-disease/)
- [Tay–Sachs disease](https://durgical.com/en/conditions/tay-sachs-disease/)
- [Niemann–Pick disease](https://durgical.com/en/conditions/niemann-pick-disease/)
- [Fabry disease](https://durgical.com/en/conditions/fabry-disease/)
- [Krabbe disease (globoid cell leukodystrophy)](https://durgical.com/en/conditions/krabbe-disease/)
- [Metachromatic leukodystrophy](https://durgical.com/en/conditions/metachromatic-leukodystrophy/)
- [Hurler syndrome (mucopolysaccharidosis type I)](https://durgical.com/en/conditions/hurler-syndrome/)
- [Hunter syndrome (mucopolysaccharidosis type II)](https://durgical.com/en/conditions/hunter-syndrome/)
- [I-cell disease (mucolipidosis II)](https://durgical.com/en/conditions/i-cell-disease/)
- [Pompe disease (glycogen storage disease type II)](https://durgical.com/en/conditions/pompe-disease/)
- [Sandhoff disease](https://durgical.com/en/conditions/sandhoff-disease/)
- [Sanfilippo syndrome (mucopolysaccharidosis type III)](https://durgical.com/en/conditions/sanfilippo-syndrome/)
- [Morquio syndrome (mucopolysaccharidosis type IV)](https://durgical.com/en/conditions/morquio-syndrome/)

## Related

- [Sphingolipids and sphingolipidoses](https://durgical.com/en/biochemistry/topics/sphingolipids-and-sphingolipidoses/)
- [Glycosaminoglycans (mucopolysaccharides)](https://durgical.com/en/biochemistry/topics/glycosaminoglycans/)
- [Mannose 6-phosphate tagging (sending enzymes to the lysosome)](https://durgical.com/en/biochemistry/topics/mannose-6-phosphate-tagging/)
- [Cell organelles and their metabolism](https://durgical.com/en/biochemistry/topics/cell-organelles-and-their-metabolism/)
- [Glucocerebrosidase (acid β-glucosidase)](https://durgical.com/en/biochemistry/enzymes/glucocerebrosidase/)
- [Hexosaminidase A (β-hexosaminidase A)](https://durgical.com/en/biochemistry/enzymes/hexosaminidase-a/)
- [α-Galactosidase A](https://durgical.com/en/biochemistry/enzymes/galactosidase-a/)
- [Acid sphingomyelinase](https://durgical.com/en/biochemistry/enzymes/acid-sphingomyelinase/)
- [α-L-Iduronidase](https://durgical.com/en/biochemistry/enzymes/l-iduronidase/)

## Test yourself

Think of the answer, then tap the question to see it.

## Why does enzyme replacement not improve brain damage in most lysosomal diseases?

The recombinant enzyme is a large protein that does not cross the blood–brain barrier.

## Which classic lysosomal diseases are X-linked?

Fabry and Hunter (MPS II); the others are autosomal recessive.

## What decides whether a lysosomal disease is infantile or adult-onset?

Residual enzyme activity: less activity means earlier and more severe disease.

## How does replacement enzyme reach the cell's lysosomes?

By endocytosis through mannose 6-phosphate or mannose receptors on the cell surface.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/biochemistry/topics/lysosomal-storage-diseases/)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: [Lysosome Vesicle Biogenesis](https://reactome.org/PathwayBrowser/#/R-HSA-432720) (Reactome, 2026); [Glycosphingolipid metabolism](https://reactome.org/PathwayBrowser/#/R-HSA-1660662) (Reactome, 2026); [Glycosaminoglycan metabolism](https://reactome.org/PathwayBrowser/#/R-HSA-1630316) (Reactome, 2026); [Gaucher disease: MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/gaucher-disease/) (MedlinePlus, US National Library of Medicine, 2026); Textbook of Biochemistry for Medical Students, 6th ed. (Jaypee Brothers Medical Publishers (Vasudevan DM, Sreekumari S, Vaidyanathan K), 2011).

[← All of biochemistry](https://durgical.com/en/biochemistry/)

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/biochemistry/topics/lysosomal-storage-diseases/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/biochemistry/topics/lysosomal-storage-diseases/
